Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -39.16% is 959% below its 5-year average of 4.56%, near the low end of its 5-year range (-39.16%–79.69%).
As of the fiscal period ended Tuesday, June 30, 2026. 14.82% below its 12-month average of -34.10%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -39.16%.
RETURN ON INVESTED CAPITAL (ROIC)
-39.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-34.10%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-31.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
4.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-14.82%
CURRENT VS 3Y AVG
-26.05%
CURRENT VS 5Y AVG
-959.13%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.75%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-547.75%
vs the sector median at left
Moderna, Inc.
Market Cap
$57.13B
Return on Invested Capital (ROIC)
-39.16%
TTM Avg
-34.10%
3Y Avg
-31.06%
5Y Avg
4.56%
Market Cap
$54.94B
Return on Invested Capital (ROIC)
13.45%
TTM Avg
12.41%
3Y Avg
9.39%
5Y Avg
5.98%
Market Cap
$62.57B
Return on Invested Capital (ROIC)
12.75%
TTM Avg
15.09%
3Y Avg
14.58%
5Y Avg
14.67%
Market Cap
$63.88B
Return on Invested Capital (ROIC)
10.57%
TTM Avg
7.46%
3Y Avg
6.12%
5Y Avg
5.55%
Market Cap
$49.21B
Return on Invested Capital (ROIC)
4.52%
TTM Avg
3.25%
3Y Avg
5.37%
5Y Avg
7.01%
Market Cap
$49.00B
Return on Invested Capital (ROIC)
3.72%
TTM Avg
4.38%
3Y Avg
4.32%
5Y Avg
3.88%
Market Cap
$48.58B
Return on Invested Capital (ROIC)
10.22%
TTM Avg
11.08%
3Y Avg
14.46%
5Y Avg
15.87%
Market Cap
$43.20B
Return on Invested Capital (ROIC)
6.79%
TTM Avg
3.17%
3Y Avg
0.33%
5Y Avg
-0.73%
Market Cap
$43.09B
Return on Invested Capital (ROIC)
8.32%
TTM Avg
8.41%
3Y Avg
8.23%
5Y Avg
6.99%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | $57.13B | -39.16% | -34.10% | -31.06% | 4.56% |
| Cardinal Health, Inc. (CAH)vs › | $54.94B | 13.45% | 12.41% | 9.39% | 5.98% |
| Cencora, Inc. (COR)vs › | $62.57B | 12.75% | 15.09% | 14.58% | 14.67% |
| Boston Scientific Corporation (BSX)vs › | $63.88B | 10.57% | 7.46% | 6.12% | 5.55% |
| Humana Inc. (HUM)vs › | $49.21B | 4.52% | 3.25% | 5.37% | 7.01% |
| Becton, Dickinson and Company (BDX)vs › | $49.00B | 3.72% | 4.38% | 4.32% | 3.88% |
| Edwards Lifesciences Corporation (EW)vs › | $48.58B | 10.22% | 11.08% | 14.46% | 15.87% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $43.20B | 6.79% | 3.17% | 0.33% | -0.73% |
| IQVIA Holdings Inc. (IQV)vs › | $43.09B | 8.32% | 8.41% | 8.23% | 6.99% |
| Agilent Technologies, Inc. (A)vs › | $41.50B | 11.88% | 12.59% | 13.58% | 12.74% |
ROIC
-39.2%
ROE
-46.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -39.16% |
| 2026-03-31 | -37.32% |
| 2025-12-31 | -29.70% |
| 2025-09-30 | -32.97% |
| 2025-06-30 | -31.36% |
| 2025-03-31 | -33.59% |
| 2024-12-31 | -33.05% |
| 2024-09-30 | -19.80% |
| 2024-06-30 | -34.81% |
| 2024-03-31 | -35.81% |
| 2023-12-31 | -27.51% |
| 2023-09-30 | -17.69% |
| 2023-06-30 | 2.73% |
| 2023-03-31 | 22.21% |
| 2022-12-31 | 39.30% |
| 2022-09-30 | 60.75% |
| 2022-06-30 | 72.98% |
| 2022-03-31 | 79.69% |
| 2021-12-31 | 78.58% |
| 2021-09-30 | 64.45% |
| 2021-06-30 | 47.77% |
| 2021-03-31 | 13.77% |
| 2020-12-31 | -25.89% |
| 2020-09-30 | -19.47% |
| 2020-06-30 | -15.47% |
| 2020-03-31 | -27.72% |
| 2019-12-31 | -37.80% |
| 2019-09-30 | -39.44% |
| 2019-06-30 | -34.41% |
| 2019-03-31 | -28.99% |
| 2018-12-31 | -23.76% |
| 2018-09-30 | -23.19% |
| 2018-06-30 | -20.27% |
| 2017-12-31 | -30.16% |
